BIOMAT Database Logo BIOMAT Database Logo

Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas. 1976

L H Baker, and M K Samson, and R M Izbicki

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D003537 Cystadenoma A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed) Cystadenomas
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

L H Baker, and M K Samson, and R M Izbicki
Oral cytembena absorption and phase I--II studies.
March 1978, Cancer treatment reports,
L H Baker, and M K Samson, and R M Izbicki
Phase II trial of cytembena in patients with advanced ovarian and breast cancer.
November 1976, Cancer treatment reports,
L H Baker, and M K Samson, and R M Izbicki
A phase I study of cytembena.
March 1976, Cancer,
L H Baker, and M K Samson, and R M Izbicki
Phase II evaluation of cytembena (NSC-104801) in patients with advanced ovarian carcinoma resistant to alkylating agents: brief communication.
December 1977, Journal of the National Cancer Institute,
L H Baker, and M K Samson, and R M Izbicki
Phase II evaluation of AMSA in adult sarcomas.
January 1981, Cancer treatment reports,
L H Baker, and M K Samson, and R M Izbicki
Phase II evaluation of chlorozotocin in metastatic sarcomas.
January 1984, Medical and pediatric oncology,
L H Baker, and M K Samson, and R M Izbicki
Phase II evaluation of bleomycin in patients with advanced epithelial ovarian cancer.
March 1984, Cancer treatment reports,
L H Baker, and M K Samson, and R M Izbicki
Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
October 1998, Gynecologic oncology,
L H Baker, and M K Samson, and R M Izbicki
A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer.
June 2004, Gynecologic oncology,
L H Baker, and M K Samson, and R M Izbicki
[Ca 125 in epithelial ovarian cancers of FIGO stage I].
January 1993, Gynakologisch-geburtshilfliche Rundschau,
Copied contents to your clipboard!